Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Korean J Intern Med
Autori principali: Jung, Seung Min, Kwok, Seung-Ki, Ju, Ji Hyeon, Park, Yong-Beom, Park, Sung-Hwan
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association of Internal Medicine 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/
https://ncbi.nlm.nih.gov/pubmed/29172405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi